tiprankstipranks
Trending News
More News >
Formycon AG (DE:FYB)
XETRA:FYB
Germany Market

Formycon AG (FYB) Stock News & Sentiment

Compare
23 Followers
Formycon AG: Strategic Developments and Positive Outlook Justify Buy Rating Despite Revenue Shortfall
Premium
Ratings
Formycon AG: Strategic Developments and Positive Outlook Justify Buy Rating Despite Revenue Shortfall
1M ago
Formycon AG: Strong Market Position and Growth Prospects Justify Buy Rating
Premium
Ratings
Formycon AG: Strong Market Position and Growth Prospects Justify Buy Rating
3M ago
Is FYB a Buy, Before Earnings?
Premium
Pre-Earnings
Is FYB a Buy, Before Earnings?
3M ago

FYB News on the Web

News Score - Last 7 Days

Neutral
DE:FYB
Sector Average
Media Buzz
This Week1 articles
Weekly Average1 articles
News Sentiment
This Week59%
Sector Average56%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:FYB’s Media Buzz Sentiment?
1 articles about DE:FYB were published this week. In an average week, 1 articles are published.
    What is DE:FYB’s weekly average amount of articles?
    In an average week, 1 articles about DE:FYB are published.
      What is DE:FYB’s News Sentiment?
      59% of articles about DE:FYB were positive this week, compared to its sector average of 56%.
        Healthcare Stocks that are Trending in the News
        USNAUSANA Health
        OGNOrganon
        ENSGThe Ensign Group
        ABTAbbott Laboratories
        DMPDermapharm Holding SE
        Showing the stocks with the most bullish news sentiment over the past week
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis